Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
By M. Chakos, J. Lieberman, E. Hoffman, D. Bradford, B. Sheitman. American Journal of Psychiatry, 2001
620 citations recorded by the source corpus.
Subfields: Clinical Psychology, Psychiatry and Mental health, Philosophy
View Paper: https://www.semanticscholar.org/paper/53aaed806f92d191375f13f71df3fe064595541d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
- Hans-Jürgen Möller
- R. Keefe
- Susan M. Shortreed
- Eric B. Laber
- Erica E. Moodie
- Daniel J. Lizotte
- J. Coyle
- Susan A. Murphy
In Philosophy
Citations in the corpus
- A meta-analysis of the efficacy of second-generation antipsychotics. (2003, methodology): “We performed (1) a metaanalysis of randomized efficacy trials comparing SGAs and FGAs, (2) comparisons between SGAs, (3) a doseresponse analysis of FGAs and SGAs, and (4) an analysis of the effect on efficacy of an overly high dose of an FGA comparator.”
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (2005, neutral): “Anticholinergic agents 25 (7) 11 (3) 32 (9) 26 (10) 14 (8) 0.”
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, background): “However, the results, except for clozapine, are inconclusive (Chakos et al. 2001).”
- Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (2006, background): “drugs in patients with chronic schizophrenia (7, 8).”